|
Zdraveski, Z Z; Mello, J A; Marinus, M G et al. (2000) Multiple pathways of recombination define cellular responses to cisplatin. Chem Biol 7:39-50
|
|
Trimmer, E E; Essigmann, J M (1999) Cisplatin. Essays Biochem 34:191-211
|
|
Avery, A M; Kaur, B; Taylor, J S et al. (1999) Substrate specificity of ultraviolet DNA endonuclease (UVDE/Uve1p) from Schizosaccharomyces pombe. Nucleic Acids Res 27:2256-64
|
|
Pourquier, P; Ueng, L M; Fertala, J et al. (1999) Induction of reversible complexes between eukaryotic DNA topoisomerase I and DNA-containing oxidative base damages. 7, 8-dihydro-8-oxoguanine and 5-hydroxycytosine. J Biol Chem 274:8516-23
|
|
Loeb, L A; Essigmann, J M; Kazazi, F et al. (1999) Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc Natl Acad Sci U S A 96:1492-7
|
|
Zhai, X; Beckmann, H; Jantzen, H M et al. (1998) Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factor. Biochemistry 37:16307-15
|
|
Trimmer, E E; Zamble, D B; Lippard, S J et al. (1998) Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities. Biochemistry 37:352-62
|
|
Kreutzer, D A; Essigmann, J M (1998) Oxidized, deaminated cytosines are a source of C --> T transitions in vivo. Proc Natl Acad Sci U S A 95:3578-82
|
|
Kobertz, W R; Wang, D; Wogan, G N et al. (1997) An intercalation inhibitor altering the target selectivity of DNA damaging agents: synthesis of site-specific aflatoxin B1 adducts in a p53 mutational hotspot. Proc Natl Acad Sci U S A 94:9579-84
|
|
Verghis, S B; Essigmann, J M; Kadlubar, F F et al. (1997) Specificity of mutagenesis by 4-aminobiphenyl: mutations at G residues in bacteriophage M13 DNA and G-->C transversions at a unique dG(8-ABP) lesion in single-stranded DNA. Carcinogenesis 18:2403-14
|
Showing the most recent 10 out of 44 publications
